 "Photo: Shutterstock")
A common treatment for prostate cancer may increase the risk for heart disease.
A study in the British Journal of Cancer identified 7,637 men in California who had new diagnoses of localised prostate cancer from 1998 to 2008 and followed them through 2010.
About 30 per cent of the men received androgen deprivation therapy, or ADT, a drug treatment that deprives prostate cancer cells of male sex hormones, which encourage their growth.
Men who did not have pre-existing cardiovascular disease who underwent ADT had an 81 per cent increased relative risk for heart failure compared with men who did not get the drug
